
Georges Caouette
Chercheur associé
Axe Reproduction, santé de la mère et de l'enfant
Publications
-
article Papenburg J, Defoy I, Massé E, Caouette G, Lebel MH
Impact of the Withdrawal of Palivizumab Immunoprophylaxis on the Incidence of Respiratory Syncytial Virus (RSV) Hospitalizations Among Infants Born at 33 to 35 Weeks’ Gestationa…
J Pediatric Infect Dis Soc 10 (3), 2021.
-
article Papenburg J, Saleem M, Teselink J, Li A, Caouette G, Massé É and Lanctôt KL
Cost-analysis of Withdrawing Immunoprophylaxis for Respiratory Syncytial Virus in Infants Born at 33-35 Weeks Gestational Age in Quebec: A Multicenter Retrospective Study
Pediatr Infect Dis J 39 (8), 2020.
-
article Paes B, Mitchell I, Li A, Lanctot KL and
A comparative study of respiratory syncytial virus (RSV) prophylaxis in premature infants within the Canadian Registry of Palivizumab (CARESS)
Eur J Clin Microbiol Infect Dis 31 (10), 2012.
Projets
- Maternal Omega-3 supplementation to reduce Bronchopulmonary Dysplasia in very Preterm Infants : A Randomized controlled trial (MOBYDIck trial), du 2014-07-01 au 2025-12-25